주식/증권 📈 긍정적

BofA upgrades Moderna after 177% rally driven by cancer vaccine breakthrough

Yahoo Finance 2026/08/20 07:32:38 5회

요약

Investing.com -- Bank of America upgraded Moderna to Neutral with a $170 price objective, following a sharp rally in the stock after positive data on its personalized cancer vaccine, intismeran, in adjuvant melanoma.

원문 기사 보기

관련 뉴스

Panoro Energy ASA GAAP EPS of -$0.06, revenue of $25.4M

2026/08/20

VGP SA reports 1H results

2026/08/20

CTO Realty Growth, Inc. 6.375% SER A PFD declares $0.3984 dividend

2026/08/20

Moderna nearly triples in record S&P 500 move, but analyst sees more volatility ahead

2026/08/20

뉴스 목록으로